These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 17311566)

  • 1. Prodrug strategy for enhancing drug delivery via skin.
    Fang JY; Leu YL
    Curr Drug Discov Technol; 2006 Sep; 3(3):211-24. PubMed ID: 17311566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current prodrug design for drug discovery.
    Hsieh PW; Hung CF; Fang JY
    Curr Pharm Des; 2009; 15(19):2236-50. PubMed ID: 19601825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of transdermal apomorphine delivery with a diester prodrug strategy.
    Liu KS; Sung KC; Al-Suwayeh SA; Ku MC; Chu CC; Wang JJ; Fang JY
    Eur J Pharm Biopharm; 2011 Aug; 78(3):422-31. PubMed ID: 21315820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ester prodrugs of morphine improve transdermal drug delivery: a mechanistic study.
    Wang JJ; Sung KC; Huang JF; Yeh CH; Fang JY
    J Pharm Pharmacol; 2007 Jul; 59(7):917-25. PubMed ID: 17637185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transdermal delivery of nalbuphine and its prodrugs by electroporation.
    Sung KC; Fang JY; Wang JJ; Hu OY
    Eur J Pharm Sci; 2003 Jan; 18(1):63-70. PubMed ID: 12554074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prodrugs for transdermal drug delivery - trends and challenges.
    Ita KB
    J Drug Target; 2016 Sep; 24(8):671-8. PubMed ID: 26878159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ketorolac amide prodrugs for transdermal delivery: stability and in vitro rat skin permeation studies.
    Kim BY; Doh HJ; Le TN; Cho WJ; Yong CS; Choi HG; Kim JS; Lee CH; Kim DD
    Int J Pharm; 2005 Apr; 293(1-2):193-202. PubMed ID: 15778057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prodrugs: a challenge for the drug development.
    Zawilska JB; Wojcieszak J; Olejniczak AB
    Pharmacol Rep; 2013; 65(1):1-14. PubMed ID: 23563019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transdermal delivery and cutaneous targeting of antivirals using a penetration enhancer and lysolipid prodrugs.
    Diblíková D; Kopečná M; Školová B; Krečmerová M; Roh J; Hrabálek A; Vávrová K
    Pharm Res; 2014 Apr; 31(4):1071-81. PubMed ID: 24271238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dermal and transdermal delivery: prodrugs.
    Sloan KB; Devarajan-Ketha H; Wasdo SC
    Ther Deliv; 2011 Jan; 2(1):83-105. PubMed ID: 22833927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro permeation of a pegylated naltrexone prodrug across microneedle-treated skin.
    Milewski M; Yerramreddy TR; Ghosh P; Crooks PA; Stinchcomb AL
    J Control Release; 2010 Aug; 146(1):37-44. PubMed ID: 20678989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prodrugs of gestodene for matrix-type transdermal drug delivery systems.
    Lipp R; Laurent H; Günther C; Riedl J; Esperling P; Täuber U
    Pharm Res; 1998 Sep; 15(9):1419-24. PubMed ID: 9755895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of ester promoieties on transdermal delivery of ketorolac.
    Liu KS; Hsieh PW; Aljuffali IA; Lin YK; Chang SH; Wang JJ; Fang JY
    J Pharm Sci; 2014 Mar; 103(3):974-86. PubMed ID: 24481782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The co-drug of conjugated hydroquinone and azelaic acid to enhance topical skin targeting and decrease penetration through the skin.
    Hsieh PW; Al-Suwayeh SA; Fang CL; Lin CF; Chen CC; Fang JY
    Eur J Pharm Biopharm; 2012 Jun; 81(2):369-78. PubMed ID: 22469554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential of Piperazinylalkylester Prodrugs of 6-Methoxy-2-Naphthylacetic Acid (6-MNA) for Percutaneous Drug Delivery.
    Pawar V; Thosani R; Kanhed A; Giridhar R; Yadav MR
    AAPS PharmSciTech; 2015 Jun; 16(3):518-27. PubMed ID: 25370023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prodrug strategies for enhancing the percutaneous absorption of drugs.
    N'Da DD
    Molecules; 2014 Dec; 19(12):20780-807. PubMed ID: 25514222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delivery of nalbuphine and its prodrugs across skin by passive diffusion and iontophoresis.
    Sung KC; Fang JY; Hu OY
    J Control Release; 2000 Jun; 67(1):1-8. PubMed ID: 10773323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prodrug design to improve pharmacokinetic and drug delivery properties: challenges to the discovery scientists.
    Jana S; Mandlekar S; Marathe P
    Curr Med Chem; 2010; 17(32):3874-908. PubMed ID: 20858214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of piperazinylalkyl ester prodrugs of ketorolac and their in vitro evaluation for transdermal delivery.
    Qandil A; Al-Nabulsi S; Al-Taani B; Tashtoush B
    Drug Dev Ind Pharm; 2008 Oct; 34(10):1054-63. PubMed ID: 18608464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterisation of the Molecular Mechanism of Permeation of the Prodrug Me-5ALA across the Human
    Kadyrov J; Ruiz-Perez L; Benson HAE; Mancera RL
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.